Esophageal Undifferentiated Carcinoma
2 clinical trials · Condition
◉ Watch Esophageal Undifferentiated Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944) | Roswell Park Cancer Institute | 2010-09-01 |
Track Esophageal Undifferentiated Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.